Figures computed from official regulatory filings — .
Analysttarget 17 USD (+68%) · consensus 4.25/5 · 3 buy · 1 hold · 0 sell
Ownershipinsiders 1.97% · institutions 92.77% · short 13.3% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for ADMA BIOLOGICS, INC. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
132 buys64 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Kestenberg-Messina Kaitlin M. | Other | $26.6K | SEC |
| Kohler Terry | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Kohler Terry | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Grossman Jerrold Btrack record | Buy | $50.6K | conv 33 | SEC |
| Grossman Jerrold Btrack record | Buy | $100.1K | conv 35 | SEC |
| Grossman Jerrold Btrack record | Buy | $100.1K | conv 44First in 12mo | SEC |
| Kestenberg-Messina Kaitlin M. | Other | $185.5K | SEC |
| Grossman Adam Strack record | Sell | $91K | SEC |
| Grossman Adam Strack record | Exercise | $81K | SEC |
| Guiheen Lawrence P.track record | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Grossman Adam Strack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Guiheen Lawrence P.track record | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Guiheen Lawrence P.track record | Exercise | $109.8K | SEC |
| Grossman Adam Strack record | Sell | $227.4K | SEC |
| Guiheen Lawrence P.track record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Kestenberg-Messina Kaitlin M. | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Kestenberg-Messina Kaitlin M. | Sell | $157.8K | SEC |
| Kestenberg-Messina Kaitlin M. | Exercise | $3.6K | SEC |
| Kestenberg-Messina Kaitlin M. | Exercise | $3.4K | SEC |
| Kestenberg-Messina Kaitlin M. | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Kestenberg-Messina Kaitlin M. | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Kestenberg-Messina Kaitlin M. | Exercise | $7.5K | SEC |
| Kestenberg-Messina Kaitlin M. | Other | $154.8K | SEC |
| Grossman Adam Strack record | Other | $868.6K | SEC |
| Kestenberg-Messina Kaitlin M. | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |